Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphisms
- 作者Laurent Macchi; Luc Christiaens; Severine Brabant; Nathalie Sorel; Stephanie Ragot; Joseph Allal; Gérard Mauco; André Brizard
- 卷第42卷
- 期第6期
- 文件大小89.08KB
- 发表时间2003
- DOI10.1016/s0735-1097(03)00921-5
- 页码1115-1119
The vulnerable plaque and acute coronary syndromesRoberto Corti; Michael E Farkouh; Juan Jose Badimon · 2002
Acute Coronary Syndromes, Myocardial Infarction, Thrombectomy and Vulnerable PlaqueCatheterization and Cardiovascular Interventions · 2014
Acute coronary syndromes, myocardial infarction, thrombectomy and vulnerable plaqueCatheterization and Cardiovascular Interventions · 2015
Acute coronary syndromes, myocardial infarction, thrombectomy and vulnerable plaqueCatheterization and Cardiovascular Interventions · 2016
Vulnerable plaque imaging and acute coronary syndromeHorváth, Martin; Hájek, Petr; Štěchovský, Cyril; Veselka, Josef · Cor et Vasa · 2014
Genomic and Personalized Medicine || Atherosclerosis, Vulnerable Plaques, and Acute Coronary SyndromesBentzon, Jacob Fog · 2013
Plaque Vulnerability, Plaque Rupture, and Acute Coronary Syndromes: (Multi)-Focal Manifestation of a Systemic Disease ProcessSchoenhagen, P.; Tuzcu, E. M.; Ellis, S. G. · Circulation · 2002
Acute coronary syndromes: Targeting the vulnerable atherosclerotic plaque – new approaches for stabilization and regression of the plaqueSivaram Pillarisetti; Uday Saxena · 2008